Literature DB >> 24005035

VEGF-Trap decreases CD4+ T cells, Th17 cytokines improving psoriasis-like skin inflammation in KC-Tie2 mice.

Doina Diaconu1, Yi Fritz, Sean M Dawes, Candace M Loyd, Nicole L Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24005035      PMCID： PMC3926202          DOI： 10.1016/j.jdermsci.2013.08.005

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  9 in total

Review 1.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

2.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

3.  Sorafenib-associated remission of psoriasis in hypernephroma: case report.

Authors:  Christa Fournier; Glenn Tisman
Journal:  Dermatol Online J       Date:  2010-02-15

4.  Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis.

Authors:  Keehoon Jung; Donghun Lee; Hye Song Lim; Sang-Il Lee; Yeon Jung Kim; Gyun Min Lee; Sun Chang Kim; Gou Young Koh
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

5.  Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.

Authors:  Helia B Schonthaler; Reto Huggenberger; Stefanie K Wculek; Michael Detmar; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

6.  Complete remission of psoriasis following bevacizumab therapy for colon cancer.

Authors:  A Akman; E Yilmaz; H Mutlu; M Ozdogan
Journal:  Clin Exp Dermatol       Date:  2008-12-09       Impact factor: 3.470

7.  Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.

Authors:  Yu-Ping Xia; Baosheng Li; Donna Hylton; Michael Detmar; George D Yancopoulos; John S Rudge
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

8.  Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.

Authors:  Rainer Kunstfeld; Satoshi Hirakawa; Young-Kwon Hong; Vivien Schacht; Bernhard Lange-Asschenfeldt; Paula Velasco; Charles Lin; Edda Fiebiger; Xunbin Wei; Yan Wu; Daniel Hicklin; Peter Bohlen; Michael Detmar
Journal:  Blood       Date:  2004-04-20       Impact factor: 22.113

9.  Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis.

Authors:  Julie A Wolfram; Doina Diaconu; Denise A Hatala; Jessica Rastegar; Dorothy A Knutsen; Abigail Lowther; David Askew; Anita C Gilliam; Thomas S McCormick; Nicole L Ward
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307
  9 in total
  1 in total

1.  Erlotinib-induced skin inflammation is IL-1 mediated in KC-Tie2 mice and human skin organ culture.

Authors:  Nicole L Ward; Narasimharao Bhagathavula; Andrew Johnston; Sean M Dawes; Wen Fu; Sylviane Lambert; Michael K Dame; Roscoe L Warner; Johann E Gudjonsson; James Varani; James T Elder
Journal:  J Invest Dermatol       Date:  2014-10-13       Impact factor: 8.551
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.